Applications, hearings, determinations, etc.: Lilly del Caribe, Inc.,

FR, July 29, 1998Notices › Drug Enforcement Administration

Linked as:

Text




Federal Register: July 29, 1998 (Volume 63, Number 145)NoticesPage 40543From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr29jy98-102

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Registration

By Notice dated April 3, 1998, and published in the Federal Register on April 14, 1998, (63 FR 18227), Lilly del Caribe, Inc., Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico 00680, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of dextropropoxyphene (9273), a basic class of controlled substance listed in Schedule II.

The firm plans to manufacture bulk product for distribution to its customers.

DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Lilly del Caribe, Inc. to manufacture dextropropoxyphene is consistent with the public interest at this time. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic class of controlled substance listed above is granted.

Dated: July 13, 1998. John H. King. Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

FR Doc. 98-20178Filed7-28-98; 8:45 amBILLING CODE 4410-09-M

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company